Clinical Trials Browser

Mesothelioma, Malignant, Colonic Neoplasms, Fallopian Tube Neoplasms, Liposarcoma, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Rhabdomyosarcoma, Sarcoma, Stomach Neoplasms, Desmoplastic Small Round Cell Tumor

NCT06820424 2025-02-11

Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

30 enrolled

Other solid neoplasm

CDH17-positive Advanced Solid Tumors

NCT06713148 2025-02-06

Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Not yet recruiting

42 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT06718946 2025-02-06

Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

38 enrolled

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT05908773 2025-01-28

A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors

Phase EARLY_PHASE1 Completed

1 enrolled

Other solid neoplasm

Advanced Solid Tumor

Clinical Trials

A IIT Study of 177Lu-DOTA-SNA040

AMT-676 in Patients With Advanced Solid Tumors

Exploratory Clinical Study of ¹⁷⁷Lu-CTR-FAPI in Patients With Metastatic Solid Tumors

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

WTX-212C-IIT

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors

Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

RAD202

Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors

This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors

Clever Peptide

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE

Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06

A Study of TIL in Advanced Solid Tumors (DFGD)

A Study of GC101 TIL in Advanced Solid Tumors (TR)

CAR-T for Claudin18.2 Positive Solid Tumors

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours

CleavHER

Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors

HF50

A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors

Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

Personalized KSX01-TCRT in Patients With Advanced Solid Tumors

TOASTIT

Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors